1. Pathophysiology of the metabolic syndrome
Emma McCracken, MRCP (UK), Monica Monaghan, MBBCh, BAO, BSc, PhD, MRCP (UK), Shiva Sreenivasan, FRCP Edin, FRCP 
Clinics in Dermatology 
Volume 36, Issue 1, Pages (January 2018)
DOI: /j.clindermatol
Copyright © Terms and Conditions

2. Fig. 1
Schematic diagram of the mechanism of action of insulin on intracellular signaling pathways. GLUT4, glucose transporter 4 (an insulin transporter regulated by insulin); GSK3, glycogen synthase kinase 3; PI3K, phosphoinositide 3-kinase; PKA, protein kinase A.
Clinics in Dermatology  , 14-20DOI: ( /j.clindermatol )
Copyright © Terms and Conditions

3. Fig. 2
NADPH Nicotinamide adenine dinucleotide phosphate; IL-6 Interleukin-6; TNF-α Tumour necrosis factor alpha; PAI-1 Plasminogen activator inhibitor-1; OxLDL Oxidized low density lipoprotein.
Schematic diagram of the role of inflammatory and oxidative mediators in the pathogenesis of atherosclerosis in the metabolic syndrome.
Clinics in Dermatology  , 14-20DOI: ( /j.clindermatol )
Copyright © Terms and Conditions